Projected incremental cost effectiveness ratios of potential interventions to improve HCV follow-up.

QALY = Quality-adjusted life year; ICER = incremental cost-effectiveness ratio.
Costs and QALYs are lifetime and discounted at an annual rate of 3%. Costs are in 2011 U.S.$ and rounded to the nearest $100. All QALYs are rounded to the nearest hundredth.
aThe ICER of linkage compared to standard of care is $26,500/QALY gained; linkage is extended dominated.
bThe ICER of treatment initiation compared to standard of care is $19,200/QALY gained; treatment initiation is extended dominated.
cThe ICER of peer navigators compared to standard of care is $20,000/QALY gained.